![System.Func`1[System.String]](/siteassets/images/z-mckesson-logosicons/health-systems2.png)
The most downloaded content by health system pharmacy leaders in August 2025.
What are biosimilars?
Essential steps to help health systems better prepare for disruptions.
By
Date
February 14, 2022
By: McKesson MedSurg Editorial Team
Read time: 5 minutes
There are important differences between biosimilars and biologics. research and studies show that the use of biosimilar drugs can save money for both patients and providers, and increased affordability of biosimilars can have a meaningful impact on the healthcare system.
To dive deeper into the differences, examining the costs and benefits, Derek Burns and Tim Ho, clinical specialists at McKesson, share their insights on biosimilars and discuss their expert knowledge of these new products.
Related Stories
With available labor resources dwindling and a shrinking pipeline, health systems must find creative solutions for better using the personnel and partnerships they have.
At this year's event, our experts heard from health systems who may be underutilizing available tools and resources in 340B program management.
Click through this interactive experience for a closer look at what you can expect at this year’s HealthTrust University Conference.
Our experts continue shaping industry conversations through regular conference and event engagements, like the HealthTrust University 340B Summit.
The most downloaded content by health system pharmacy leaders in July 2025.
A recent podcast includes first-hand insights on opportunities for collaboration in strengthening the supply chain to achieve more.
The top three Prescribed Perspectives articles downloaded by health systems in June.
This visual helps illustrate the nuances of each type of bagging in specialty pharmacy and what it may mean for your health system.
As strategic partners, our Specialty Pharmacy Enablement experts can help drive improvements across the board.